Le Lézard
Classified in: Health, Science and technology
Subject: AWD

CSL CEO Paul Perreault Earns 2018 Most Admired CEOs Recognition from the Philadelphia Business Journal


KING OF PRUSSIA, Pa., Dec. 6, 2018 /PRNewswire/ -- Paul Perreault, CEO and Managing Director of CSL Limited, is one of the Philadelphia Business Journal's Most Admired CEOs for 2018, recognizing his patient-focused leadership of the world's fifth largest biotechnology company.

CSL Behring logo. (PRNewsFoto/CSL Behring)

"In choosing the winners of the Most Admired CEO Awards, the editorial board of the Philadelphia Business Journal looks for evidence of true leadership ? at the company, organization or firm and in the community," said Craig Ey, Editor-in-Chief, Philadelphia Business Journal. "We considered accomplishments, leadership traits and community service in selecting this year's honorees."

Since taking the helm of CSL in 2013, Perreault has led the company on an unprecedented journey ? enhancing a dynamic portfolio of lifesaving medicines, including those that treat hemophilia, hereditary angioedema and immune deficiencies, as well as vaccines to prevent influenza. Through its two businesses: CSL Behring, a global leader in providing lifesaving biotherapies for people stricken with rare and serious diseases, with operational headquarters in King of Prussia; and Seqirus, the world's second largest influenza vaccine provider, CSL medicines now reach patients in more than 60 countries.

"I have the best job in the world," Perreault said. "For more than a century, the people of CSL have delivered on our promise to develop and provide innovative medicines and programs for people with serious medical conditions. It is a privilege to lead more than 22,000 'Chief Patient Officers' ? employees who are dedicated to working every day as if someone's life depends on it, because it does."

During Perreault's tenure as CEO, CSL's global employment has nearly doubled and the company's sustainable growth is expected to continue. In 2017, Forbes magazine named CSL among the Top 50 employers in the world for the first time and, in 2018, Thomson Reuters ranked CSL as one of the top 100 companies in its global Diversity and Inclusion Index. 

Company revenue for its fiscal year 2018 was $7.9 billion, up 11 percent at constant currency from the prior year. Additionally ? CSL's share price has more than tripled since Perreault assumed the role of CEO.

For more information about Paul Perreault, please click here.

About CSL Behring
CSL Behring is a global biotherapeutics leader driven by its promise to save lives. Focused on serving patients' needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease and neurological disorders. The company's products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic disease of the newborn.

CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. The parent company, CSL Limited (ASX: CSL; USOTC: CSLLY), headquartered in Melbourne, Australia, employs more than 22,000 people, and delivers its lifesaving therapies to people in more than 60 countries. For inspiring stories about the promise of biotechnology, visit Vita at CSLBehring.com/Vita and follow us on Twitter.com/CSLBehring.

 

SOURCE CSL Behring


These press releases may also interest you

at 05:34
Sungrow, a global leading PV inverter and energy storage system supplier, has emerged as one of the standout companies on the 2024 Fortune Asia Future 30 list. The list, which recognizes the most promising companies in Asia Pacific, is a testament to...

at 05:30
Cato Networks, the SASE leader, announced a new SASE throughput record here at the Porsche Studio Ginza ahead of the 2024 Tokyo E-Prix, achieving 10 Gbps without hardware upgrades. At 10 Gbps, Cato became the first SASE platform to compete not only...

at 05:20
Roborock, a global leader in ultra-intelligent home robotics engineered to simplify daily life, today announced it has taken the number one spot for robotic vacuum sales worldwide, according to new data by Euromonitor. Celebrating its achievements at...

at 05:20
IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, today announced that China National Medical Products Administration (NMPA) has approved the...

at 05:15
The "Flow Cytometry Markets. Forecasts by Technology, Product and Application. With Executive and Consultant Guides. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. The technology is moving faster than the market. Find the...

at 05:00
TAL Education Group ("TAL" or the "Company") , a smart learning solutions provider in China, today announced that it will release its unaudited financial results for the fourth quarter and fiscal year 2024 ended February 29, 2024, before the market...



News published on and distributed by: